Fundz

Neurolens reported raising $67.6 Million in an initial SEC Form D filing, from an offering of $67.6 Million

PRIVATESep 13, 2022

Amount Raised

$67.6 Million

$67.6 Million sold, per SEC Form D (first sale Sep 1, 2022)

Round Type

Venture

CoppellBiotechnologyMedical Device

Quick answer

Neurolens raised $67.6 Million in a funding round, dated September 1, 2022. Neurolens is based in Coppell, Texas, United States.

How much did Neurolens raise?
Neurolens raised $67.6 Million in a funding round on September 1, 2022.
What does Neurolens do?
As many as 80% of people experience reduced visual acuity and symptoms due to eye misalignment.
Where is Neurolens based and how big is it?
Neurolens is based in Coppell, Texas, United States.
Who are the decision-makers at Neurolens?
Fundz holds 1 contact at Neurolens, including the Director. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Medical Device and Biotechnology around the same time

Companies in the same sectors as Neurolens that raised within 45 days of this round, from Fundz verified event records.

  • Xtant Medical Holdings raised $9.8M on October 11, 2022.
  • Starlight Cardiovascular raised $9.5M (Series A) on October 4, 2022.
  • Acurable raised $11M (Series A) on October 3, 2022.
  • US Medical Innovations raised $10M (Post-IPO Equity) on September 21, 2022.
  • Embody raised $10M (Series C) on September 20, 2022.
  • Surgimate raised an undisclosed amount (Corporate Round) on September 20, 2022.

Who to call at Neurolens, and when

A new round usually means Neurolens is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Neurolens raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Neurolens, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Neurolens. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Neurolens

Location

1234 Lakeshore Drive #200

Coppell, Texas, United States

About

As many as 80% of people experience reduced visual acuity and symptoms due to eye misalignment. Even small misalignments can cause poor vision and painful symptoms, and even small prism corrections can provide dramatic results. Historically, however, measuring small amounts of prism has been all but impossible. But now is the time to transform your practice with Neurolens. Our newest innovation, N3, is an immersive, engaging patient experience that educates while measuring. N3 is a fast and accurate way for any eyecare provider to measure eye misalignment down to a fraction of a prism diopter. The diagnostic information from N3 is used to prescribe Neurolenses with patented contoured prism technology, which bring the eyes into alignment, relieving symptoms like headaches and eye strain for 93% of wearers. Learn more about becoming a Neurolens provider at neurolens.com and join the new standard of care providing dramatic patient outcomes and practice success.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Neurolens raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsTom F., Director hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Neurolens's next move

See what Strategic adds

Neurolens raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.